Market Overview

Bank of America Merrill Lynch Reiterates Buy Rating, $40 PT on HCA Holdings

Share:
Related HCA
Senate Unveils Its Version of Trumpcare: Healthcare Stocks Up
Should Value Investors Pick HCA Healthcare (HCA) Stock Now?
CBO Deals Blow To Senate's TrumpCare Bill; Sen. Collins To Vote No (Investor's Business Daily)

In a report published Wednesday, Bank of America Merrill Lynch reiterated its Buy rating and $40.00 price target on HCA Holdings (NYSE: HCA).

BofA Merrill Lynch noted, “Highlander Partners, L.P., a private investment firm, announced that Martin, Fletcher, one of its portfolio companies, has been acquired by Parallon Business Solutions, HCA's subsidiary. Martin Fletcher is a staffing company which will fit nicely into the Parallon's offering, in our view. We note that in Feb. 2011 HCA created a new subsidiary to sell its internally focused services businesses externally. While initially the external business will be relatively small, it does provide an avenue of growth that its peers lack.”

HCA Holdings closed on Tuesday at $32.98.

Latest Ratings for HCA

DateFirmActionFromTo
Jun 2017Morgan StanleyInitiates Coverage OnEqual-Weight
Jun 2017Leerink SwannUpgradesMarket PerformOutperform
Apr 2017Deutsche BankInitiates Coverage OnBuy

View More Analyst Ratings for HCA
View the Latest Analyst Ratings

Posted-In: Bank of America Merrill LynchAnalyst Color Reiteration Analyst Ratings

 

Related Articles (HCA)

View Comments and Join the Discussion!